Equol is an intestinal bacterial metabolite derived from the isoflavone daidzein and has beneficial health effects. Most equol producers belong to the family Coriobacteriaceae, which includes species such as Adlercreutzia equolifaciens. Here, we report the draft genome sequence of A. equolifaciens IPLA 37004, a human isolate that does not produce equol.
A mong isoflavones and their metabolites, the bacterial daidzein-derived compound (S)-(Ϫ)-equol has the strongest estrogenic activity (1) and antioxidant action (2) , by which it can positively influence human health (3) . However, only 30 to 60% of humans harbor equol-producing microbes in their intestines. Most equol-producing bacteria belong to the family Coriobacteriaceae of the phylum Actinobacteria, which includes species such as Adlercreutzia equolifaciens, Asaccharobacter celatus, Enterorhabdus mucosicola, Slackia isoflavoniconvertens, and Slackia equolifaciens (3). However, whether equol production is a family-, species-, or strain-specific characteristic is not yet known.
Strain IPLA 37004 was isolated from fecal samples from a woman with an equolproducing microbiota, using agar plates of Gifu anaerobic medium (GAM) (Nissui) supplemented with 5 g liter Ϫ1 arginine (GAM-Arg; Merck) and cultivation under strict anaerobic conditions. Sequencing and sequence comparison of the 16S rRNA gene of IPLA 37004 identified the strain as A. equolifaciens. Surprisingly, the strain did not produce equol when cultured in GAM-Arg with isoflavones, daidzein, or dihydrodaidzein. To get insights regarding its non-equol-producing phenotype, the genome of A. equolifaciens IPLA 37004 was sequenced, and its sequence was analyzed.
After growth of the strain in GAM-Arg, total genomic DNA from IPLA 37004 was extracted and purified using the DNeasy blood and tissue kit (Qiagen), as suggested by the manufacturer. For genome sequencing, a library was constructed using SPRIworks fragment library system I (Beckman Coulter), according to the manufacturer's instructions. Paired-end sequencing (2 ϫ 150-bp reads) was performed at Eurofins Genomics on a HiSeq sequencer (Illumina) (sequence mode, NovaSeq 6000; S2 flow cell; pairedend 150-bp reads; Xp flowchart). The average genome coverage approached 100ϫ, yielding a total of 5,568,276 bp of adapter-free and quality-filtered reads after the use of Trimmomatic (4) and FastQC (5) software packages. De novo assembly of qualityfiltered nontrimmed reads in contigs was accomplished using SPAdes v3.6.2 (6), setting the parameters with a k value of 125 or 127 and only-assembler. Then, the NCBI Prokaryotic Genome Annotation Pipeline (7) was used to predict and annotate the open reading frames. Whole-genome comparisons were achieved by using the multiple genome alignment software package Mauve v2.3.1 (8) . Finally, BLAST v2.10.0 searches (BLASTp suite, NCBI) were used to determine homology between proteins of different strains.
The 
